Skip to main content
Earnings Labs
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL)

NASDAQ·Healthcare·Biotechnology

$12.61

+1.21%

Mkt Cap $279.31M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (7 analysts)

$46.00

Range $44.00$49.00

Implied Upside

+264.8%

Consensus $46.00 vs current $12.61